• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New
Melanoma, An Issue of Surgical Oncology Clinics of North America

Melanoma, An Issue of Surgical Oncology Clinics of North America

9780443317606
463.63 zł
394.09 zł Save 69.54 zł Tax included
Lowest price within 30 days before promotion: 394.09 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Surgical Oncology Clinics, guest editor Dr. Genevieve Boland brings her considerable expertise to the topic of Melanoma. Top experts provide a timely update on management of melanoma, with articles on nodal management, stage 4 surgery, margins, systemic therapy, and neoadjuvant therapy, as well as vaccines in melanoma and ocular and mucosal melanoma.
Product Details
Elsevier
103545
9780443317606
9780443317606

Data sheet

Publication date
2025
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
152 x 229
Weight (g)
450
  • Margins for Melanoma: Extent of Resection, Alternative Approaches, and Future Considerations
    Age and Sex Correlations with Melanoma Outcomes (Nodal Status, Survival Melanoma in Pregnancy, and Spitzoid Lesions)
    Nodal Management in Melanoma: Is Nodal Staging Needed, What Is the Value, and What Is the Extent of Surgery?
    Systemic Therapy for Melanoma: What Surgeons Need to Know
    Neoadjuvant Therapy: Changes in the Management of Macroscopic Stage III/ Resectable Stage IV Melanoma
    Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic Therapy
    Vaccines in Melanoma: Past, Present, and Future
    Adoptive T-Cell Therapy in Melanoma: How This Will Impact Surgical Practice and the Role of Surgeons
    Predictive Biomarkers for Immune Checkpoint Inhibitor Therapy in Advanced Melanomas
    Non-Cutaneous Melanoma: Biology, Clinical Management, Current Therapy, and Future Directions in Treatment
Comments (0)